Tamoxifen is effective in curing breast cancer ?

Tamoxifen is effective in curing breast cancer ?

Tamoxifen is effective in curing breast cancer ?

Tamoxifen , which is known in the trade as Nolvadex , is usually prescribed by specialists in breast cancer and is taken in pill form. A patient will be tested for the drug for about five years.Often of women cancer to see if the amount of estrogen in the system will remain sensitive . If the cancer is estrogen sensitive , tamoxifen will given.Because tamoxifen is such a weak estrogen , estrogen signals do not stimulate his very cell growth. And because it has stolen the place of the more powerful estrogen, it blocks estrogen -stimulated growth of cancer cells. In this way, tamoxifen acts as an "anti - estrogen ".


Tamoxifen can also take the place of the natural estrogen receptors of healthy breast cells. In this way it keeps the activity and growth may stop abnormal growth and development of an entirely new breast cancer. By blocking natural estrogen from , to the receptors tamoxifen is helpful in reducing the risk of breast cancer in women at high risk who have never had breast cancer . It can also help women who already had breast cancer in one breast back to lowering the risk of a new breast cancer forming in the other breast.One study found that radiation plus tamoxifen was much better than tamoxifen alone come to reduce the risk of breast cancer after lumpectomy in women with hormone - receptor -positive breast cancer . This was also true for women with very small cancers.

For premenopausal women tamoxifen is the best hormonal therapy. But tamoxifen is no longer the first choice for women after menopause. If you've been on tamoxifen for two to three years, and now you're in menopause , your doctor may recommend that you switch to an aromatase inhibitor to finish your five years of hormone therapy. However, you can still have a lot of advantages if you take tamoxifen for up to five years to complete and then inhibitor.Tamoxifen to an aromatase inhibitor was first used to treat breast cancer in the Christie Hospital in Manchester, England to fight in 1969. It has proven useful as a means of preventing the spread or recurrence of the disease in women who have been treated for it.
But it was noted in the early 1980s that some women who were the drug for cancer in one breast developed no tumor growth in the other. This prompted the suggestion that tamoxifen could develop a more preventative role for those women who are at risk of getting breast cancer, but still no signs of the disease by .